… rat models were established after anesthesia and ligation on sciatic nerves. To evaluate the
pain sensitivity of CCI rats… , in our study, we found that propofol decreased GFAP, TNF-α, IL-…

… PWLs in CCI rats were significantly decreased on postoperative days … This study found that
CCI rats had a higher level of M1 … the development of NP by inhibiting M1 microglia activation, …

… To determine whether early treatment with PPARγ agonist could suppress the development
… study, we found that the spinal expression of PPARγ was significantly reduced in PINP rats. …

… attenuated established paclitaxel-induced neuropathic pain … the development of peripheral
neuropathic pain in Wistar rats… a PPARγ agonist, reduces cisplatin-evoked neuropathic pain …

… sensory neuropathy, often accompanied by neuropathic pain … the development of PIPN in
C57BL/6J male and female mice. … In addition, this lipid-lowering drugs have an established …

… both inflammatory and neuropathic pain as discussed later. … in PPARγ knockout mice. De
Guglielmo et al. (2014) … of PPARα or PPARγ activation at multiple sites within the pain pathway, …

… neuropathic pain in mouse and rat is only 3–10 mg/kg, equivalent to 15–49 mg/kg in human.
This is lower than … We found that the RCR was compromised in the cortex of mice with the …

… in the peroxisome growth factor activated receptor (PPAR) … Considering the lower glucose
observed in KD rats, we also … , it was found that KD alleviated the severity of neuropathic …

… pain [19], neuropathic pain [20], and other chronic pain [21]. … We found that intrathecal
injection of rosiglitazone reduced … Sprague-Dawley rats and cancerous ascites developed after 6…

… for their ability to reduce peripheral neuropathic pain [11, 12]. … and PPARγ agonists to alleviate
peripheral neuropathic pain… the development of chemotherapy-induced neuropathic pain, …